Clinical diagnosis of hepatic fibrosis using human serum APOL1 as biomarker
The inventors have proposed a novel panel of human serum protein biomarkers for diagnosing hepatic fibrosis and cirrhosis. Presently there is no reliable non-invasive way of assessing liver fibrosis. A 2D-PAGE based proteomics study was used to identify potential fibrosis biomarkers. Serum from pati...
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Patent |
| Argitaratua: |
European Patent Office
2012
|